Form 8-K - Current report:
SEC Accession No. 0001193125-24-062154
Filing Date
2024-03-07
Accepted
2024-03-07 16:02:04
Documents
21
Period of Report
2024-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802391d8k.htm   iXBRL 8-K 33336
2 EX-99.1 d802391dex991.htm EX-99.1 34580
3 EX-99.2 d802391dex992.htm EX-99.2 7518
4 EX-99.3 d802391dex993.htm EX-99.3 7448
5 EX-99.4 d802391dex994.htm EX-99.4 5752
9 GRAPHIC g802391ex99_2p1g1.jpg GRAPHIC 649627
10 GRAPHIC g802391ex99_3p1g1.jpg GRAPHIC 688272
11 GRAPHIC g802391ex99_4p1g1.jpg GRAPHIC 602067
  Complete submission text file 0001193125-24-062154.txt   2911335

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bmea-20240306.xsd EX-101.SCH 2864
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20240306_lab.xml EX-101.LAB 18736
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20240306_pre.xml EX-101.PRE 11716
22 EXTRACTED XBRL INSTANCE DOCUMENT d802391d8k_htm.xml XML 3760
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 24729960
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)